vs

Side-by-side financial comparison of POTLATCHDELTIC CORP (PCH) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $158.6M, roughly 2.0× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 8.2%, a 62.9% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 23.1%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $50.1M).

PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

PCH vs STOK — Head-to-Head

Bigger by revenue
PCH
PCH
2.0× larger
PCH
$314.2M
$158.6M
STOK
Growing faster (revenue YoY)
STOK
STOK
+3638.0% gap
STOK
3661.1%
23.1%
PCH
Higher net margin
STOK
STOK
62.9% more per $
STOK
71.2%
8.2%
PCH
More free cash flow
STOK
STOK
$81.6M more FCF
STOK
$131.7M
$50.1M
PCH

Income Statement — Q3 FY2025 vs Q1 FY2025

Metric
PCH
PCH
STOK
STOK
Revenue
$314.2M
$158.6M
Net Profit
$25.9M
$112.9M
Gross Margin
18.2%
Operating Margin
11.2%
70.2%
Net Margin
8.2%
71.2%
Revenue YoY
23.1%
3661.1%
Net Profit YoY
682.5%
528.0%
EPS (diluted)
$0.33
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCH
PCH
STOK
STOK
Q3 25
$314.2M
Q2 25
$275.0M
Q1 25
$268.3M
$158.6M
Q4 24
$258.1M
$22.6M
Q3 24
$255.1M
Q2 24
$320.7M
Q1 24
$228.1M
Q4 23
$254.5M
Net Profit
PCH
PCH
STOK
STOK
Q3 25
$25.9M
Q2 25
$7.4M
Q1 25
$25.8M
$112.9M
Q4 24
$5.2M
$-10.5M
Q3 24
$3.3M
Q2 24
$13.7M
Q1 24
$-305.0K
Q4 23
$-140.0K
Gross Margin
PCH
PCH
STOK
STOK
Q3 25
18.2%
Q2 25
13.0%
Q1 25
17.8%
Q4 24
13.4%
Q3 24
10.8%
Q2 24
11.9%
Q1 24
7.0%
Q4 23
8.1%
Operating Margin
PCH
PCH
STOK
STOK
Q3 25
11.2%
Q2 25
5.0%
Q1 25
10.3%
70.2%
Q4 24
5.2%
-60.4%
Q3 24
2.8%
Q2 24
5.4%
Q1 24
-2.1%
Q4 23
0.0%
Net Margin
PCH
PCH
STOK
STOK
Q3 25
8.2%
Q2 25
2.7%
Q1 25
9.6%
71.2%
Q4 24
2.0%
-46.4%
Q3 24
1.3%
Q2 24
4.3%
Q1 24
-0.1%
Q4 23
-0.1%
EPS (diluted)
PCH
PCH
STOK
STOK
Q3 25
$0.33
Q2 25
$0.09
Q1 25
$0.33
$1.90
Q4 24
$0.07
$-0.15
Q3 24
$0.04
Q2 24
$0.17
Q1 24
$0.00
Q4 23
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCH
PCH
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$88.8M
$274.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
$350.1M
Total Assets
$3.2B
$406.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCH
PCH
STOK
STOK
Q3 25
$88.8M
Q2 25
$95.3M
Q1 25
$147.5M
$274.8M
Q4 24
$151.6M
$128.0M
Q3 24
$161.1M
Q2 24
$199.7M
Q1 24
$180.2M
Q4 23
$230.1M
Total Debt
PCH
PCH
STOK
STOK
Q3 25
Q2 25
Q1 25
Q4 24
$1.0B
Q3 24
Q2 24
Q1 24
Q4 23
$1.0B
Stockholders' Equity
PCH
PCH
STOK
STOK
Q3 25
$1.9B
Q2 25
$1.9B
Q1 25
$2.0B
$350.1M
Q4 24
$2.0B
$229.0M
Q3 24
$2.1B
Q2 24
$2.1B
Q1 24
$2.2B
Q4 23
$2.2B
Total Assets
PCH
PCH
STOK
STOK
Q3 25
$3.2B
Q2 25
$3.2B
Q1 25
$3.3B
$406.9M
Q4 24
$3.3B
$271.6M
Q3 24
$3.3B
Q2 24
$3.4B
Q1 24
$3.4B
Q4 23
$3.4B
Debt / Equity
PCH
PCH
STOK
STOK
Q3 25
Q2 25
Q1 25
Q4 24
0.51×
Q3 24
Q2 24
Q1 24
Q4 23
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCH
PCH
STOK
STOK
Operating Cash FlowLast quarter
$65.7M
$131.8M
Free Cash FlowOCF − Capex
$50.1M
$131.7M
FCF MarginFCF / Revenue
15.9%
83.0%
Capex IntensityCapex / Revenue
4.9%
0.1%
Cash ConversionOCF / Net Profit
2.54×
1.17×
TTM Free Cash FlowTrailing 4 quarters
$132.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCH
PCH
STOK
STOK
Q3 25
$65.7M
Q2 25
$41.0M
Q1 25
$49.1M
$131.8M
Q4 24
$45.4M
$-23.2M
Q3 24
$26.5M
Q2 24
$100.6M
Q1 24
$16.0M
Q4 23
$41.8M
Free Cash Flow
PCH
PCH
STOK
STOK
Q3 25
$50.1M
Q2 25
$30.6M
Q1 25
$26.3M
$131.7M
Q4 24
$25.4M
$-23.2M
Q3 24
$-8.2M
Q2 24
$72.4M
Q1 24
$2.0M
Q4 23
FCF Margin
PCH
PCH
STOK
STOK
Q3 25
15.9%
Q2 25
11.1%
Q1 25
9.8%
83.0%
Q4 24
9.9%
-102.7%
Q3 24
-3.2%
Q2 24
22.6%
Q1 24
0.9%
Q4 23
Capex Intensity
PCH
PCH
STOK
STOK
Q3 25
4.9%
Q2 25
3.8%
Q1 25
8.5%
0.1%
Q4 24
7.7%
0.2%
Q3 24
13.6%
Q2 24
8.8%
Q1 24
6.1%
Q4 23
Cash Conversion
PCH
PCH
STOK
STOK
Q3 25
2.54×
Q2 25
5.58×
Q1 25
1.90×
1.17×
Q4 24
8.74×
Q3 24
7.99×
Q2 24
7.35×
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PCH
PCH

Lumber$131.8M42%
Timberlands$52.5M17%
Rural Real Estate$51.3M16%
Residuals And Panels$34.0M11%
Pulpwood$16.7M5%
Development Real Estate$14.6M5%
Other$8.1M3%
Other Products$5.2M2%

STOK
STOK

Segment breakdown not available.

Related Comparisons